MelphalanTransplantation, AutologousAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionMultiple MyelomaBlood Transfusion, AutologousHematopoietic Stem Cell TransplantationCombined Modality TherapyMyeloablative AgonistsBone Marrow TransplantationAntineoplastic Combined Chemotherapy ProtocolsCarmustineTransplantation ConditioningCyclophosphamideStem Cell TransplantationThiotepaAmyloidosisTreatment OutcomePrednisonePeripheral Blood Stem Cell TransplantationVincristineRemission InductionThalidomideEtoposideBusulfanMelanomaWhole-Body IrradiationBoronic AcidsPyrazinesDisease-Free SurvivalMisonidazoleButhionine SulfoximineTransplantation, HomologousMethionine SulfoximineLymphoma, Non-HodgkinBone Marrow PurgingSalvage TherapyCytarabineHodgkin DiseaseSurvival AnalysisAlkylating AgentsDoxorubicinDexamethasoneAntineoplastic AgentsDose-Response Relationship, DrugHematopoietic Stem Cell MobilizationChlorambucilRecurrenceTime FactorsSurvival RateLomustineRats, NudeDrug SynergismStomatitisCell SurvivalFollow-Up StudiesVidarabineDrug ResistanceExtremitiesT-LymphocytesDrug Administration ScheduleNitrogen Mustard CompoundsCytotoxicity, ImmunologicGranulocyte Colony-Stimulating FactorSemustineAntigens, CD34Bone MarrowLeukapheresisHematologic NeoplasmsGraft SurvivalLymphocyte Culture Test, MixedPodophyllotoxinDrug Screening Assays, AntitumorParaproteinsTumor Cells, CulturedCarboplatinLymphocyte ActivationSarcomaT-Lymphocytes, CytotoxicHyperthermia, InducedAlfaxalone Alfadolone MixtureCells, CulturedDrug EvaluationRetrospective StudiesSarcoma, ExperimentalFlunarizineCell TransplantationRhabdomyosarcomaNeuroblastomaPrognosisLymphocytesAntigens, NeoplasmNitroimidazolesImmunoglobulin Light Chains